JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD.

Highlights Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 19/06/2024 am IST			5-day change	1st Jan Change
8.21 ^CNY	-0.61%		-3.18%	-26.30%

02:32pm	China Grants Active Pharmaceutical Ingredient Marketing Approval for Lianhuan Pharma's Cardiac Treatment	MT
05/06	China Approves Lianhuan Pharma's Prostate Cancer Tablets	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Lianhuan Pharma Obtains China Registration Approval for Antihistamine	09/04	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03	CI
Lianhuan Pharma's Production Lines Pass GMP Inspection	07/11	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Jiangsu Lianhuan Pharma Plans Listing Unit on ‘New Third Board’	12/23/12	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/23/25	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Lianhuan Pharma Gets Nod for Erectile Dysfunction Drug	06/23/06	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	02/23/02	CI
Jiangsu Lianhuan Pharmaceutical Gets Nod to Market Antihistamine Ingredient in China	10/23/10	MT
Lianhuan Pharma Gets Nod for Anti-Allergy Drug Registration	09/23/09	MT
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/22/21	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/22/24	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	27/22/27	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	24/21/24	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/21/29	CI
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	30/21/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Equities

600513

CNE000001DP6

Highlights

Filters